Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden · Delayed Price · Currency is SEK 11.68
-0.06 (-0.51%)
Aug 13, 2026, 5:29 PM CET
Vicore Pharma Holding AB Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Vicore Pharma Holding AB stock has a consensus rating of "Strong Buy" and an average price target of kr 29.25. The average 1-year stock price forecast is 150.43% higher than the current stock price, while the lowest is kr 15.00 (+28.42%) and the highest is kr 38.00 (+225.34%).
Price Target: kr 29.25 (+150.43%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jun 9, 2026.
Analyst Ratings
The average analyst rating for Vicore Pharma Holding AB stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 | 6 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates kr 33.00 | Buy | Initiates | kr 33.00 | +182.53% | Jun 9, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates kr 38.00 | Buy | Reiterates | kr 38.00 | +225.34% | May 7, 2026 |
Financial Forecast
Revenue This Year
9.68M
from 3.82M
Increased by 153.69%
Revenue Next Year
52.14M
from 9.68M
Increased by 438.48%
EPS This Year
-1.71
from -1.99
EPS Next Year
-1.34
from -1.71
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.